reports
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Markus Henriksson
- Viktor Stenlöf
Eurohold Bulgaria AD: 1 director
A director at Eurohold Bulgaria AD sold 755,000 shares at 0.930BGN and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Saizeriya Company: 1 director
A director at Saizeriya Company sold 20,000 shares at 5,162.000JPY and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all ...
Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions PRESS RELEASE Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions Shareholders approve a total dividend of €2.08 per ordinary share Alphen aan den Rijn – May 8, 2024 – Wolters Kluwer (Euronext: WKL), a global leader of professional information, software solutions, and services, announces that all resolutions were adopted as proposed at today’s Annual General Meeting of Shareholders (AGM). Composition Supervisory Board has been appointed as a member of the Supervisory Board of...
Gilat Reports First Quarter 2024 Results
Gilat Reports First Quarter 2024 Results Strong Revenue Growth of 29% Year-over-Year, GAAP Operating Income of $5.4 Million and Adjusted EBITDA of $9.3 Million PETAH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today reported its results for the first quarter, ended March 31, 2024. First Quarter 2024 Financial Highlights Revenue of $76.1 million, up 29% compared with $59.0 million in Q1 2023;GAAP operating income of $5.4 million, c...
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Result...
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call MINNEAPOLIS, May 08, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the first quarter 2024 after the market closes on Wednesday, May 15, 2024. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update. Webcast and Conference Call Information To ...
Vertex Announces First Quarter 2024 Financial Results
Vertex Announces First Quarter 2024 Financial Results KING OF PRUSSIA, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2024. “The year is off to a solid start, and I am very pleased with our financial performance in the first quarter,” stated David DeStefano, Vertex’s President, Chief Executive Officer and Chairperson of the Board. “Revenue traction is strong in the first quarter, with our cloud solutions leading the w...
Olema Oncology Announces New Clinical Data for Palazestrant in Combina...
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress Olema will host an investor conference call at 8:00 a.m. ET on May 15, 2024 SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that it will present new clinical data from the Company’s ongoing Phase 1b/2 clinical study of palazestrant...
The New York Times Company Reports First-Quarter 2024 Results
NEW YORK--(BUSINESS WIRE)-- The New York Times Company (NYSE: NYT) announced today that its first-quarter 2024 financial results are available on The New York Times Company’s investor relations website at . As previously announced, The New York Times Company will host its earnings conference call today at 8:00 a.m. E.T. to discuss these results. A live webcast of the earnings conference call will be available at . Participants can pre-register for the telephone conference at , which will generate dial-in instructions allowing participants to bypass an operator at the time of the call. Altern...
Black Diamond Group Limited Announces Renewal of Normal Course Issuer ...
Black Diamond Group Limited Announces Renewal of Normal Course Issuer Bid CALGARY, Alberta, May 08, 2024 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (TSX: BDI) (“Black Diamond” or the “Company”) announces that it has obtained approval of the Toronto Stock Exchange (the “TSX”) to renew its normal course issuer bid (the “NCIB”) with respect to its common shares (the “Common Shares”). The NCIB will commence on May 10, 2024, and will terminate on the earlier of May 9, 2025, the date on which the Company has purchased the maximum number of Common Shares permitted under the NCIB or the date...
SpringWorks Therapeutics to Participate in the BofA Securities 2024 He...
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference STAMFORD, Conn., May 08, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at the BofA Securities 2024 Health Care Conference, taking place in Las Vegas, Nevada on Tuesday, May 14, 2024 at 3:40 p.m. PT / 6:40 p.m. ET. To access the live webcast, please visit the Events & Presentations page within the Investors & Media sect...
Sprott Announces First Quarter 2024 Results
Sprott Announces First Quarter 2024 Results TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the quarter ended March 31, 2024. Management commentary “Sprott’s AUM once again reached record highs during the quarter, driven by stronger gold and silver prices late in the period, offset somewhat by what we view as short-term weakness in uranium and related equities. As of March 31, 2024, AUM was $29.4 billion, up $0.6 billion from the end of 2023. Subsequent to quarter end, on May 6, 2024, AUM stood at...
Brink's Announces Strong First-Quarter Results and Affirms Full Year G...
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance Record First Quarter Revenue Reflecting 4% Growth and 12% Organic GrowthGAAP net income up 229% to $49M and record adjusted EBITDA up 15% to $218MGAAP EPS up 263% to $1.09 and non-GAAP EPS up 20% to $1.52TTM GAAP Net Cash from Operations up 56% to $800M: non-GAAP Free Cash Flow up 61% to $363M RICHMOND, Va., May 08, 2024 (GLOBE NEWSWIRE) -- The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables management, digital retail solutions (DRS), and ATM managed services (AMS), today announced f...
Tata Consumer Products Ltd: 1 director
A director at Tata Consumer Products Ltd sold 27,000 shares at 1,095.950INR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Xiabuxiabu Catering Management (China) Holdings Co. Ltd: 1 director
A director at Xiabuxiabu Catering Management (China) Holdings Co. Ltd bought 18,075,000 shares at 1.607HKD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compan...
- ABGSC Telecom Operators Research
- Oscar Rönnkvist
- Øystein Elton Lodgaard
- Simon Granath
GDS to Report First Quarter 2024 Financial Results Before the Open of ...
GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024 SHANGHAI, China, May 08, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced that it will report its first quarter 2024 unaudited financial results after the close of the Hong Kong market and before the open of the U.S. market on May 22, 2024. The Company’s management will host an earnings conference call at 8:00 AM ...
Brunswick Exploration Drills 93.45 Meters at 1.55% Li2O at MR-6
Brunswick Exploration Drills 93.45 Meters at 1.55% Li2O at MR-6 MONTREAL, May 08, 2024 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to report more significant results from the Mirage winter drilling campaign. The Mirage Project is located in the Eeyou Istchee-James Bay region of Quebec approximately 40 kilometres south from the Trans-Taiga Road. The winter drill campaign focused on the Central Zone and has continued to intersect multiple wide well mineralized intervals on the MR-6 dyke and its vicinity where it remains open i...
Cartesian Therapeutics Reports First Quarter 2024 Financial Results an...
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update Topline data from Phase 2b trial of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis on track for mid-2024 On track to dose first patient in Phase 2 trial of Descartes-08 in SLE in 2Q24, as well as Phase 2 basket studies in additional autoimmune indications in 2H24 New headquarters expected to support scale of wholly owned, in-house cGMP manufacturing capabilities for clinical and commercial supply of Com...
OKYO Pharma Announces Participation in May 2024 Investor Conferences
OKYO Pharma Announces Participation in May 2024 Investor Conferences LONDON and NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, today announced upcoming presentations at two investor conferences in May 2024. Conference: Aegis Capital Vi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.